BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jamali R, Razavizade M, Arj A, Aarabi MH. Serum adipokines might predict liver histology findings in non-alcoholic fatty liver disease. World J Gastroenterol 2016; 22(21): 5096-5103 [PMID: 27275102 DOI: 10.3748/wjg.v22.i21.5096]
URL: https://www.wjgnet.com/1007-9327/full/v22/i21/5096.htm
Number Citing Articles
1
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. Iron as a therapeutic target in chronic liver diseaseWorld Journal of Gastroenterology 2023; 29(4): 616-655 doi: 10.3748/wjg.v29.i4.616
2
Timon Adolph, Christoph Grander, Felix Grabherr, Herbert Tilg. Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple InteractionsInternational Journal of Molecular Sciences 2017; 18(8): 1649 doi: 10.3390/ijms18081649
3
Bai Li, Li Fang, Enfa Zhao. Research Progress on the Mechanism of Acupuncture Treatment for Nonalcoholic Fatty Liver DiseaseGastroenterology Research and Practice 2022; 2022: 1 doi: 10.1155/2022/5259088
4
Chiara Mele, Graziano Grugni, Stefania Mai, Roberta Vietti, Gianluca Aimaretti, Massimo Scacchi, Paolo Marzullo. Circulating angiopoietin-like 8 (ANGPTL8) is a marker of liver steatosis and is negatively regulated by Prader-Willi SyndromeScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-03538-7
5
Chi Zhang, Nan Zhou, Ping Qiu, Yuming Fu, Zefa Liu, Hongxia Li, Xiangjun Yang, Lei Zhang. Serum C1q/TNF-related protein 9 is not related to nonalcoholic fatty liver diseaseCytokine 2018; 110: 52 doi: 10.1016/j.cyto.2018.04.019
6
Josh Bilson, Jaswinder K. Sethi, Christopher D. Byrne. Non-alcoholic fatty liver disease: a multi-system disease influenced by ageing and sex, and affected by adipose tissue and intestinal functionProceedings of the Nutrition Society 2022; 81(2): 146 doi: 10.1017/S0029665121003815
7
Letícia BALTIERI, Elinton Adami CHAIM, Felipe David Mendonça CHAIM, Murillo Pimentel UTRINI, Martinho Antonio GESTIC, Everton CAZZO. CORRELATION BETWEEN NONALCOHOLIC FATTY LIVER DISEASE FEATURES AND LEVELS OF ADIPOKINES AND INFLAMMATORY CYTOKINES AMONG MORBIDLY OBESE INDIVIDUALSArquivos de Gastroenterologia 2018; 55(3): 247 doi: 10.1590/s0004-2803.201800000-62
8
Hyunmi Kim, Da Som Lee, Tae Hyeon An, Hyun-Ju Park, Won Kon Kim, Kwang-Hee Bae, Kyoung-Jin Oh. Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCCInternational Journal of Molecular Sciences 2021; 22(9): 4495 doi: 10.3390/ijms22094495
9
Jessica Binetti, Laia Bertran, David Riesco, Carmen Aguilar, Salomé Martínez, Fàtima Sabench, Jose Antonio Porras, Javier Camaron, Daniel Del Castillo, Cristóbal Richart, Teresa Auguet. Deregulated Serotonin Pathway in Women with Morbid Obesity and NAFLDLife 2020; 10(10): 245 doi: 10.3390/life10100245
10
Marianna G. Mavilia, George Y. Wu. Liver and serum adiponectin levels in non‐alcoholic fatty liver diseaseJournal of Digestive Diseases 2021; 22(4): 214 doi: 10.1111/1751-2980.12980
11
Rafael Bergesch D’Incao, Cristiane Valle Tovo, Vanessa Suñé Mattevi, Diego Olschowsky Borges, Jane Maria Ulbrich, Gabriela Perdomo Coral, Mauricio Jacques Ramos, Nelson Guardiola Meinhardt. Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery PatientsObesity Surgery 2017; 27(8): 2151 doi: 10.1007/s11695-017-2627-4
12
Ricardo Rodríguez-Calvo, Sara Samino, Josefa Girona, Neus Martínez-Micaelo, Pere Ràfols, María García-Altares, Sandra Guaita-Esteruelas, Alexandra Junza, Mercedes Heras, Oscar Yanes, Xavier Correig, Lluis Masana. Hepatic Lipidomics and Molecular Imaging in a Murine Non-Alcoholic Fatty Liver Disease Model: Insights into Molecular MechanismsBiomolecules 2020; 10(9): 1275 doi: 10.3390/biom10091275
13
Driton Vela. Low hepcidin in liver fibrosis and cirrhosis; a tale of progressive disorder and a case for a new biochemical markerMolecular Medicine 2018; 24(1) doi: 10.1186/s10020-018-0008-7
14
Raika Jamali, Mehdi Ebrahimi, Ali Faryabi, Haleh Ashraf. Which Metabolic Index is Appropriate for Predicting Non-alcoholic Steatohepatitis?Middle East Journal of Digestive Diseases 2020; 12(2): 99 doi: 10.34172/mejdd.2020.168
15
I. Kasacka, Ż. Piotrowska, N. Domian, A. Lewandowska, M. Acewicz. Immunohistochemical identification and assessment of the location of leptin, visfatin and chemerin in the liver of men with different body mass indexBMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02299-6
16
Djuro Macut, Ivana Božić-Antić, Jelica Bjekić-Macut, Konstantinos Tziomalos. MANAGEMENT OF ENDOCRINE DISEASE: Polycystic ovary syndrome and nonalcoholic fatty liver diseaseEuropean Journal of Endocrinology 2017; 177(3): R145 doi: 10.1530/EJE-16-1063
17
Miaomiao Jin, Xiaohong Niu, Yan Liu, Dong Zhang, Danni Yuan, Huimin Shen. Effect of glucagon-like peptide-1 receptor agonists on adipokine level of nonalcoholic fatty liver disease in rats fed high-fat dietOpen Medicine 2020; 15(1): 689 doi: 10.1515/med-2020-0212
18
Abdulrahman Ismaiel, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Dan L. Dumitrascu. Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-AnalysisJournal of Clinical Medicine 2021; 10(14): 3029 doi: 10.3390/jcm10143029
19
Andrew Ndakotsu, Govinathan Vivekanandan. The Role of Thiazolidinediones in the Amelioration of Nonalcoholic Fatty Liver Disease: A Systematic ReviewCureus 2022;  doi: 10.7759/cureus.25380
20
N. R. Matkovska. CHANGES IN CARBOHYDRATE METABOLISM AND ADIPOCYTOKINES UNDER THE INFLUENCE OF TREATMENT OF PATIENTS WITH ALCOHOLIC CIRRHOSIS OF THE LIVER IN COMBINATION WITH OBESITY USING ADAMETHIONINUM AND ARGININE GLUTAMATEMedical and Clinical Chemistry 2020; (3): 17 doi: 10.11603/mcch.2410-681X.2020.v.i3.11514
21
C. Alejandra Monraz-Méndez, Rebeca Escutia-Gutiérrez, Jonathan Samael Rodriguez-Sanabria, Marina Galicia-Moreno, Hugo Christian Monroy-Ramírez, Laura Sánchez-Orozco, Jesus García-Bañuelos, Ricardo De la Rosa-Bibiano, Arturo Santos, Juan Armendáriz-Borunda, Ana Sandoval-Rodríguez. Moringa oleifera Improves MAFLD by Inducing Epigenetic ModificationsNutrients 2022; 14(20): 4225 doi: 10.3390/nu14204225
22
V. I. Podzolkov, N. A. Dragomiretskaya, S. K. Stolbova, A. V. Tolmacheva. Hepcidin and MELD-XI score as markers of multiple organ failure in patients with heart failure with preserved and reduced ejection fractionCardiovascular Therapy and Prevention 2020; 19(3): 2529 doi: 10.15829/1728-8800-2020-2529
23
Jinzhou Zhu, Mingqing He, Yong Zhang, Tingxin Li, Yuping Liu, Zhiye Xu, Weichang Chen. Validation of simple indexes for nonalcoholic fatty liver disease in western China: a retrospective cross-sectional studyEndocrine Journal 2018; 65(3): 373 doi: 10.1507/endocrj.EJ17-0466
24
V. I. Podzolkov, N. A. Dragomiretskaya, S. K. Stolbova, I. S. Rusinov. Associations of NT-proBNP and hepcidin levels with clinical and laboratory parameters in patients with heart failure with various severity of left ventricular systolic dysfunctionCardiovascular Therapy and Prevention 2020; 19(4): 2587 doi: 10.15829/1728-8800-2020-2587
25
Mónica B. Jiménez-Castro, Araní Casillas-Ramírez, Elsa Negrete-Sánchez, Cindy G. Avalos-de León, Jordi Gracia-Sancho, Carmen Peralta. Adipocytokines in Steatotic Liver Surgery/TransplantationTransplantation 2019; 103(1): 71 doi: 10.1097/TP.0000000000002098
26
Eman M. Hasan, Rasha A. Abd Al Aziz, Dina Sabry, Hedy A. Badary, Yasmine Gaber, Ayman Yosry, Zeinab Zakaria. The association of adiponectin gene polymorphisms with susceptibility and progression of NAFLD in a cohort of Egyptian patientsEgyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00103-w
27
Chrysoula Boutari, Nikolaos Perakakis, Christos Socrates Mantzoros. Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver DiseaseEndocrinology and Metabolism 2018; 33(1): 33 doi: 10.3803/EnM.2018.33.1.33
28
CHANGES IN CARBOHYDRATE METABOLISM IN PATIENTS WITH ALCOHOLIC CIRRHOSIS OF THE LIVER ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE DEPENDING ON THE STAGE OF DECOMPENSATIONInternational Academy Journal Web of Scholar 2019; (6(36)): 17 doi: 10.31435/rsglobal_wos/30062019/6551
29
Esra Akyüz Özkan, Allahverdi Sadigov, Osman Öztürk. Evaluation of Serum Omentin-1, Vaspin, Leptin, Adiponectin Levels in Obese/Overweight Children and Their Relationship With Non-Alcoholic Fatty Liver DiseaseClinical Nutrition Research 2022; 11(3): 194 doi: 10.7762/cnr.2022.11.3.194
30
Christina Tontikidou, Evangelia S Makri, Kleo Evripidou, Dimitrios G Goulis, Antonis Goulas, Stergios A Polyzos. Circulating adiponectin in patients with nonalcoholic fatty liver disease‐related liver fibrosis: A systematic review and a meta‐analysisJournal of Gastroenterology and Hepatology 2022; 37(10): 1853 doi: 10.1111/jgh.15926
31
Teresa Auguet, Laia Bertran, Jessica Binetti, Carmen Aguilar, Salomé Martínez, Fàtima Sabench, Jesús Miguel Lopez-Dupla, José Antonio Porras, David Riesco, Daniel Del Castillo, Cristóbal Richart. Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic SteatohepatitisInternational Journal of Molecular Sciences 2020; 21(11): 4189 doi: 10.3390/ijms21114189
32
Kristy L. Thomas, Callie L. Root, Jonathan M. Peterson, G. William Wong. Transgenic overexpression of CTRP3 does not prevent alcohol induced hepatic steatosis in female micePLOS ONE 2022; 17(1): e0258557 doi: 10.1371/journal.pone.0258557
33
Liuhong Shen, Yingkun Zhu, Jinbang Xiao, Bolin Qian, Tao Jiang, Junliang Deng, Guangneng Peng, Shumin Yu, Suizhong Cao, Zhicai Zuo, Xiaoping Ma, Zhijun Zhong, Zhihua Ren, Ya Wang, Ziyao Zhou, Haifeng Liu, Xiaolan Zong, Yanchun Hu. Relationships between placental adiponectin, leptin, visfatin and resistin and birthweight in cattleReproduction, Fertility and Development 2020; 32(4): 402 doi: 10.1071/RD18247
34
Dongli Han, Jie Chen, Shousheng Liu, Zengzhi Zhang, Zhenzhen Zhao, Wenwen Jin, Yongning Xin. Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysisJournal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2021.00018
35
Thomas Marjot, Ahmad Moolla, Jeremy F Cobbold, Leanne Hodson, Jeremy W Tomlinson. Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and ManagementEndocrine Reviews 2020; 41(1): 66 doi: 10.1210/endrev/bnz009
36
Nerma Čustović, Senija Rašić. Relationship of serum adiponectin and resistin levels with the severity of liver fibrosis in patients with chronic hepatitis BJournal of Medical Biochemistry 2022; 41(2): 176 doi: 10.5937/jomb0-33793
37
Raika Jamali, Soroush Veisi, Arsia Jamali, Mehdi Yaseri. Relationship Between Cardiovascular Disease Risk Factors and Quality of Life in Patients with Metabolic-Associated Fatty Liver DiseaseHepatitis Monthly 2022; 22(1) doi: 10.5812/hepatmon-124229